U.S. Capital Markets Stock News

Even though GSI Technology, Inc. ( NASDAQ:GSIT ) has fallen by 17% over the past week , insiders who sold US$154k worth...

TransMedics Group (TMDX) has closed an investment in Germany based PAD Aviation, aiming to replicate its Organ Care System Network Operating Platform across Europe and build a dedicated pan European organ transplant logistics network. See our latest analysis for TransMedics Group. At a share price of US$71.12, TransMedics Group has seen the stock climb 7.07% over the past week and 2.43% over the past month, but it remains down 42.04% year to date and the 1 year total shareholder return has...

Those following along with First Guaranty Bancshares, Inc. ( NASDAQ:FGBI ) will no doubt be intrigued by the recent...

Perrigo Company plc recently completed a major shift in the Russell index family, moving from the Russell 1000 and Midcap indices into several Russell 2000 benchmarks, while the Board added consumer-products veterans Salman Amin and Omer Gajial as independent directors on June 30, 2026. The combination of index reclassification and fresh board expertise in consumer health, retail, and e-commerce could influence how investors assess Perrigo’s scale, peer group, and strategic direction. Next,...

MeiraGTx Holdings plc recently entered into a private placement agreement to issue 2,376,426 ordinary shares at US$10.52 each for US$25,000,000 in gross proceeds, with closing of the initial sale having occurred in the past on July 17, 2026, and investors retaining the option to purchase up to an additional US$15,000,000 in shares under Regulation D. Alongside a separate agreement for up to US$400,000,000 in funding from Oberland Capital, this mix of non-dilutive royalties and new equity...

Hamilton Insurance Group, Ltd. was recently dropped from the Russell 2000 Dynamic Index but, on July 7, 2026, was added to the Zacks Rank #1 (Strong Buy) List following an 18.5% upward revision in current‑year earnings estimates over the past 60 days. This combination of index exclusion and a Zacks upgrade highlights how differing frameworks can simultaneously reduce passive index exposure while signaling increased analyst confidence in the company’s earnings outlook. Next, we’ll examine how...

In late June 2026, Mercury Systems, Inc. was removed from multiple Russell value benchmarks, including the Russell 3000 Value, 2000 Value, 2500 Value, Small Cap Comp Value, and 3000E Value indexes. This broad exclusion from key value indexes highlights how closely Mercury’s shareholder base is tied to index-tracking funds and benchmark-driven capital flows. Next, we’ll examine how Mercury’s simultaneous removal from several Russell value indexes may influence its investment narrative and...

On 27 June 2026, Ultragenyx Pharmaceutical Inc. was removed from larger-cap Russell 1000 and Midcap indices and simultaneously added to the Russell 2000, related growth and value benchmarks, and several Russell value indices, reflecting a broad reclassification within the Russell index family. This reshuffling across size and style indices can materially influence trading flows as index-tracking and benchmark-aware investors adjust their portfolios to the new compositions. With Ultragenyx...

Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...

NeuroPace, Inc. ( NASDAQ:NPCE ), is not the largest company out there, but it saw a significant share price rise of 39...

Anyone interested in Sinclair, Inc. ( NASDAQ:SBGI ) should probably be aware that the Independent Director, Daniel...

Eversource Energy, alongside National Grid and Unitil, has filed long-term contracts for three utility-scale battery storage projects in Massachusetts, totaling 1,068 MW and 4,472 MWh of capacity expected online by 2030 to support cleaner, more flexible grid operations. This large storage build-out marks a key step in Massachusetts’ push toward 5 GW of storage by 2030, highlighting Eversource’s expanding role in enabling clean peaking capacity and easing transmission congestion in Greater...

Royalty Pharma (RPRX) has just been added to both the Russell 1000 Value-Defensive Index and the Russell 1000 Defensive Index, a shift that often attracts closer attention from index-tracking and passive funds. See our latest analysis for Royalty Pharma. That index inclusion comes after a period of strong momentum for Royalty Pharma, with a 90-day share price return of 20.67%, a year-to-date share price return of 48.74%, and a 1-year total shareholder return of 66.26%. If you are using this...

The Morning Bull - US Market Morning Update Wednesday, Jul, 8 2026 US stock futures are mixed this morning, with E-mini S&P 500 contracts slightly softer while Dow futures edge higher, as investors weigh fresh signals on inflation and growth. Oil is back above $72 a barrel after tensions in the Strait of Hormuz, which makes fuel more expensive to transport and feeds worries that the cost of living could stay higher for longer. At the same time, the ISM Services PMI at 54.0 shows the largest...

Index removal puts fresh attention on Grocery Outlet Holding Grocery Outlet Holding (GO) was recently removed from both the Russell 2000 Defensive and Russell 2000 Value-Defensive indexes, an index reshuffle that can prompt trading shifts as benchmarked funds rebalance positions. See our latest analysis for Grocery Outlet Holding. For context, Grocery Outlet Holding’s share price has moved to US$10.21, with a 30-day share price return of 19.28% and a 90-day share price return of 43.80%...

SEALSQ guidance and quantum roadmap draw investor focus SEALSQ (LAES) has reaffirmed its 2026 revenue guidance of 50% to 100% growth on audited 2025 revenue of US$18.3 million, while pushing ahead with its post-quantum cryptography product and readiness strategy. See our latest analysis for SEALSQ. Despite SEALSQ’s guidance reaffirmation and progress on its post quantum roadmap, the stock’s recent momentum has cooled, with the share price down 12.5% over 30 days and the year to date share...

MercadoLibre’s share price has delivered a 61.7% gain over the past three years, yet its valuation signals are pulling in different directions, with an intrinsic value estimate from a Discounted Cash Flow (DCF) model pointing to upside while market multiples suggest the stock trades at a premium. A 61.7% return over three years suggests MercadoLibre has already rewarded investors who stayed the course. This naturally raises the bar for what counts as good value today. Recent coverage...

With inflation, interest rate debates and energy shocks all pulling markets in different directions, investors are looking for clearer, more focused ideas. The AI Small Caps screener targets smaller companies that are building early-stage tools in areas such as machine learning, automation and data intelligence. These companies are at a stage where growth potential can still be influenced by new products and adoption. This article highlights 3 stocks from that screener, giving you a curated...

Aurinia Pharmaceuticals (AUPH) is drawing fresh attention after announcing PRESERVE, a Phase 4 multicenter study testing its oral lupus nephritis drug LUPKYNIS alongside three established immune therapies. See our latest analysis for Aurinia Pharmaceuticals. The PRESERVE announcement comes after a strong period for Aurinia Pharmaceuticals, with a 1 year total shareholder return of 113.70% and a more moderate 5.67% year to date share price return. This suggests momentum that investors are now...

On 27 June 2026, Lamar Advertising was added to multiple Russell value indices and benchmarks, while being removed from the Russell 1000 Dynamic Index, reshaping its index footprint across value and mid-cap segments. This broad inclusion across Russell value and defensive indices can meaningfully influence how institutional investors classify Lamar within portfolios focused on value-oriented real estate exposure. We’ll now examine how Lamar’s expanded presence in major Russell value indices...

Global protein markets are being shaken by the Trump administration’s decision to exempt Brazilian beef from proposed 25% tariffs, and that ripple is reaching well beyond ranches. For investors, this kind of trade shock can quickly reshuffle pricing power, costs and demand across traditional meat producers and consumer protein alternatives. This article breaks down three stocks exposed to the news, highlighting one that could see a potential tailwind from shifting consumer preferences and two...

On 27 June 2026, Blue Bird Corporation was removed from several Russell Microcap and Russell 3000E benchmarks while being added to the Russell 2000 Defensive and Russell 2000 Growth-Defensive indices, reshaping its index footprint across the small-cap universe. This reshuffling across growth, microcap, and defensive indices may alter how institutional investors view Blue Bird’s profile, positioning it more squarely within defensive-oriented small-cap mandates. We’ll now examine how Blue...

Recent commentary on Medpace Holdings (MEDP) focuses less on headline growth and more on the composition of its $2.93b backlog, as shifting cancellation patterns reshape how investors view its revenue visibility. See our latest analysis for Medpace Holdings. Medpace Holdings' recent share price has been volatile, with the stock falling 3.33% on the day to $546.29 but showing a 20.26% 1 month share price return. The 1 year total shareholder return of 69.39% and 5 year total shareholder return...

Clean energy and advanced nuclear are back in the spotlight after Google, XTX Markets and others backed a €400mn funding round in fusion start-up Proxima Fusion, valuing it at €2.4bn. For investors, that kind of commitment from major tech and energy companies signals fresh attention on businesses tied to next generation power, data centers and supporting infrastructure. This article breaks down 3 stocks that appear positively exposed to this fusion driven news, helping you think through where...